Skip to main content

Table 7 Prognostic value of clinicopathological factors and TRPM7 methylation using multivariate Cox regression in Luminal A

From: Promoter methylation of transient receptor potential melastatin-related 7 (TRPM7) predicts a better prognosis in patients with Luminal A breast cancers

Characteristics

HRa (95% CI)

P

TRPM7 methylation

0.13 (0.02–0.72)

0.02

Ageb

1.04 (0.64–1.69)

0.89

LNMc

/

0.95

Endocrine therapy

0.33 (0.10–1.06)

0.06

Radiotherapy

/

0.94

Chemotherapy

1.84 (0.36–9.43)

0.46

  1. aHR: hazard ratio with 95% confidence interval (CI); bAge (per 10 years);cLymph node metastasis
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us